Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma
Trial details
- Registry ID
- NCT05188729
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Open-Label Proof of Concept Study of VP-315 in Basal Cell CarcinomaNCT05188729 | VRCA | Phase 2 | Completed | 2024-04-15Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |